Strength training program for women taking GLP-1 medication
Part of Hormones & metabolism clinical trials.
This study tests a 12-week digital strength training program for women aged 40–54 who have recently started taking a GLP-1 medication for weight management. The program uses a smartphone app to guide bodyweight exercises at home, with the goal of preserving muscle while losing weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between the ages of 40 and 54
- You started taking a GLP-1 medication (like Wegovy or Ozempic) within the last 6 months
- Your body mass index (BMI) is 27 or higher
- You have not been doing regular strength training (like lifting weights) in the past month
- You can stand, sit, and do bodyweight exercises without help
- You have a compatible smartphone (iPhone or Android) and are willing to use study apps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
This study tests whether a 12-week program of exercise and personalized nutrition can help adults who are obese and taking GLP-1 weight-loss medications maintain muscle and bone while losing fat. It aims to improve strength, fitness, and overall function during treatment.
This trial is an online survey to understand how people taking GLP-1 medications (like Ozempic or Wegovy) are doing with resistance training. If you're an adult on a stable dose of a GLP-1 med for weight or diabetes, your input can help shape better exercise advice.
This study looks at whether certain dietary supplements can help preserve muscle mass while you are taking a GLP-1 medication for weight loss. You would take the supplements or a placebo for a period while continuing your GLP-1 treatment, and the researchers will measure changes in your muscle and strength.
This study tests a 6-month behavioral program to help people keep off the weight they lost using GLP-1 or other weight-loss medications after they stop taking those medications. The program includes a 10-week foundational course, virtual sessions, and support to help you maintain your weight loss.
This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.
Hear when a new Women Health trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.